StockClub
SPPHSpencer Pharmaceutical Inc.$ --
Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc.

SPPH

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2004FY2004 Q1
Revenue
1M USD
YoY +Infinity%
Operating Income
0M USD
YoY +269.4%
Net Income
-1M USD
YoY -278.1%
EPS
-0.5$
YoY -100.0%

Revenue

$670,214
FY2002 Q2$867,341
$867,341
Q2
FY2002 Q3$1.3M
$1.3M
Q3
FY2002 Q4$2.6M
$2.6M
Q4
FY2003 Q1$0
$0
Q1
FY2003 Q2$0
$0
Q2
FY2003 Q3$0
$0
Q3
FY2003 Q4$0
$0
Q4
FY2004 Q1$670,214
$670,214
Q1
Actual
+$670,214 (-)

Net Income

$-509,685
FY2002 Q2$-1.8M
$-1.8M
Q2
FY2002 Q3$-2.4M
$-2.4M
Q3
FY2002 Q4$-2.2M
$-2.2M
Q4
FY2003 Q1$-134,800
$-134,800
Q1
FY2003 Q2$-290,468
$-290,468
Q2
FY2003 Q3$-344,919
$-344,919
Q3
FY2003 Q4$-862,541
$-862,541
Q4
FY2004 Q1$-509,685
$-509,685
Q1
Actual
$-374,885 (-278.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2001
Actual:$941,372
FY2001
$941,372
FY2002
Actual:$2.6M
FY2002
$2.6M
FY2003
Actual:$0
FY2003
$0

Analyst Estimates

No forecast data